See more : SHIFT Inc. (3697.T) Income Statement Analysis – Financial Results
Complete financial analysis of Excelsior Medical Co., Ltd. (4104.TW) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Excelsior Medical Co., Ltd., a leading company in the Medical – Devices industry within the Healthcare sector.
- DevEx Resources Limited (DEV.AX) Income Statement Analysis – Financial Results
- Société BIC SA (BICEF) Income Statement Analysis – Financial Results
- Patkol Public Company Limited (PK.BK) Income Statement Analysis – Financial Results
- Shandong Longertek Technology Co., Ltd. (300594.SZ) Income Statement Analysis – Financial Results
- Xenetic Biosciences, Inc. (XBIOW) Income Statement Analysis – Financial Results
Excelsior Medical Co., Ltd. (4104.TW)
About Excelsior Medical Co., Ltd.
Excelsior Medical Co., Ltd. distributes medical related systems in Taiwan, China, Japan, Korea, Malaysia, and the Philippines. The company offers equipment for hemodialysis, regular drug used in the medical institution, surgical equipment, and medical assistant electronics; and cosmetic equipment. It also provides medical administration services for single department. The company was founded in 1988 and is based in New Taipei City, Taiwan.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 8.23B | 7.19B | 6.57B | 6.68B | 6.46B | 6.35B | 6.10B | 6.21B | 6.20B | 5.81B | 5.74B | 6.00B | 5.99B | 15.36B | 14.30B |
| Cost of Revenue | 6.56B | 5.67B | 5.20B | 5.37B | 5.22B | 5.15B | 4.89B | 5.01B | 4.97B | 4.63B | 4.59B | 4.64B | 4.57B | 13.83B | 13.03B |
| Gross Profit | 1.67B | 1.51B | 1.37B | 1.31B | 1.24B | 1.20B | 1.21B | 1.20B | 1.23B | 1.18B | 1.15B | 1.36B | 1.42B | 1.53B | 1.27B |
| Gross Profit Ratio | 20.28% | 21.07% | 20.90% | 19.57% | 19.18% | 18.90% | 19.80% | 19.30% | 19.85% | 20.34% | 20.11% | 22.65% | 23.77% | 9.95% | 8.87% |
| Research & Development | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 350.90M | 308.09M | 261.40M | 278.62M | 304.07M | 259.32M | 270.00M | 345.13M | 383.06M | 356.33M | 349.46M | 395.91M | 352.97M | 385.83M | 346.52M |
| Selling & Marketing | 622.68M | 585.20M | 509.14M | 495.90M | 463.88M | 489.61M | 483.74M | 472.09M | 500.65M | 479.34M | 497.54M | 576.66M | 580.25M | 666.37M | 580.98M |
| SG&A | 973.59M | 893.28M | 770.54M | 774.52M | 767.95M | 748.92M | 753.74M | 817.22M | 883.71M | 835.67M | 847.00M | 972.57M | 933.22M | 1.05B | 927.49M |
| Other Expenses | 0.00 | -66.04M | -78.38M | 76.00K | 2.34M | 72.81M | 25.88M | 117.38M | 163.51M | 120.29M | 171.52M | 9.21M | 18.33M | 33.73M | 11.38M |
| Operating Expenses | 919.21M | 893.28M | 770.54M | 774.60M | 770.29M | 748.86M | 754.33M | 818.23M | 882.85M | 837.46M | 846.12M | 972.57M | 933.22M | 1.05B | 927.49M |
| Cost & Expenses | 7.53B | 6.57B | 5.97B | 6.14B | 5.99B | 5.89B | 5.64B | 5.83B | 5.85B | 5.46B | 5.43B | 5.61B | 5.50B | 14.88B | 13.96B |
| Interest Income | 65.30M | 24.90M | 10.69M | 23.26M | 44.64M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 11.11M | 6.50M | 3.22M | 2.85M |
| Interest Expense | 17.20M | 10.45M | 8.76M | 10.77M | 23.82M | 22.05M | 31.78M | 39.14M | 35.42M | 31.84M | 41.44M | 41.00M | 48.06M | 33.34M | 41.63M |
| Depreciation & Amortization | 265.68M | 222.44M | 202.95M | 167.47M | 160.24M | 80.27M | 84.82M | 93.59M | 125.39M | 123.05M | 123.22M | 130.57M | 131.42M | 100.04M | 100.56M |
| EBITDA | 968.56M | 1.09B | 972.19M | 1.01B | 934.95M | 591.20M | 563.26M | 474.99M | 707.82M | 459.26M | 579.36M | 560.36M | 678.25M | 585.60M | 524.44M |
| EBITDA Ratio | 11.76% | 15.20% | 14.79% | 15.14% | 14.48% | 12.02% | 11.01% | 11.51% | 11.41% | 10.77% | 10.09% | 9.34% | 11.54% | 4.56% | 3.83% |
| Operating Income | 702.88M | 869.86M | 769.23M | 843.06M | 774.71M | 450.24M | 452.56M | 379.50M | 348.17M | 343.50M | 308.65M | 386.32M | 491.36M | 475.00M | 341.58M |
| Operating Income Ratio | 8.54% | 12.10% | 11.70% | 12.63% | 12.00% | 7.10% | 7.42% | 6.12% | 5.61% | 5.92% | 5.38% | 6.44% | 8.20% | 3.09% | 2.39% |
| Total Other Income/Expenses | 441.20M | 93.84M | 104.50M | 300.31M | -27.89M | 198.26M | 101.68M | 199.12M | 198.84M | 126.92M | 106.05M | 61.82M | 7.40M | -22.78M | 40.68M |
| Income Before Tax | 1.14B | 963.70M | 873.74M | 829.38M | 746.83M | 648.50M | 554.24M | 578.61M | 547.02M | 470.41M | 414.70M | 456.66M | 545.30M | 536.46M | 458.49M |
| Income Before Tax Ratio | 13.90% | 13.41% | 13.29% | 12.42% | 11.57% | 10.22% | 9.09% | 9.32% | 8.82% | 8.10% | 7.22% | 7.61% | 9.10% | 3.49% | 3.21% |
| Income Tax Expense | 221.23M | 178.40M | 151.45M | 160.30M | 124.55M | 100.08M | 83.23M | 101.31M | 79.27M | 102.37M | 88.30M | 95.66M | 97.33M | 101.72M | 131.86M |
| Net Income | 746.61M | 667.45M | 607.15M | 571.67M | 514.76M | 451.56M | 399.05M | 389.56M | 379.00M | 285.68M | 299.94M | 275.79M | 333.97M | 355.69M | 311.95M |
| Net Income Ratio | 9.07% | 9.29% | 9.24% | 8.56% | 7.97% | 7.12% | 6.55% | 6.28% | 6.11% | 4.92% | 5.22% | 4.60% | 5.57% | 2.32% | 2.18% |
| EPS | 4.80 | 4.29 | 3.90 | 3.69 | 3.64 | 3.34 | 2.94 | 2.91 | 3.08 | 2.38 | 2.50 | 2.25 | 2.77 | 3.17 | 3.07 |
| EPS Diluted | 4.78 | 4.27 | 3.88 | 3.67 | 3.62 | 3.34 | 2.92 | 2.86 | 3.01 | 2.37 | 2.45 | 2.22 | 2.72 | 3.15 | 3.00 |
| Weighted Avg Shares Out | 155.62M | 155.62M | 155.62M | 155.07M | 141.28M | 135.32M | 135.71M | 133.99M | 123.17M | 120.03M | 120.32M | 120.32M | 120.57M | 112.05M | 101.50M |
| Weighted Avg Shares Out (Dil) | 156.26M | 156.41M | 156.49M | 155.91M | 142.09M | 135.32M | 136.85M | 136.68M | 126.18M | 120.48M | 125.67M | 125.73M | 125.92M | 113.14M | 105.97M |
Source: https://incomestatements.info
Category: Stock Reports